<DOC>
	<DOC>NCT01639014</DOC>
	<brief_summary>The purpose of the study is to assess the efficacy of a new serotonin-norepinephrine reuptake inhibitor (SNRI) nin functional recovery after ischemic stroke.</brief_summary>
	<brief_title>Effect of F2695 on Functional Recovery After Ischemic Stroke</brief_title>
	<detailed_description />
	<mesh_term>Stroke</mesh_term>
	<mesh_term>Ischemia</mesh_term>
	<mesh_term>Cerebral Infarction</mesh_term>
	<criteria>Male or female patient, 18 to 80 years of age Confirmed acute ischemic stroke within the past 2 10 days Unilateral motor deficit, National Institutes of Health stroke scale (NIHSS) motor score &gt;= 5 Modified Rankin Scale (mRS) of 4 or 5 Able and willing to comply with the site rehabilitation program requirements Aphasia Severe poststroke condition Active depressive episode Intracerebral hemorrhage Use of antidepressant drugs Cardiac rhythm disorder Uncontrolled arterial hypertension Other severe acute or chronic medical or psychiatric condition.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>March 2014</verification_date>
</DOC>